Ziheng Chen

5PUBLICATIONS
81CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyMetabolic medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 06, 2026
DPY30 Is an Epigenetic Decoupler Linking Replication Stress to Immunoediting in Pancreatic Cancer.

Francesca Citron, Luca Cecchetto, Elisabetta Granato

|Dec 02, 2025
GFER Represents a Target for Dual Disruption of Redox Homeostasis and Reactivation of the Immune Response in Pancreatic Adenocarcinoma.

Ziheng Chen, I-Lin Ho, Jintan Liu

|Nov 25, 2025
Nivolumab plus ipilimumab induce hyper-progression in renal medullary carcinoma: results of a phase II trial and preclinical evidence.

Melinda Soeung, Xinmiao Yan, Ciro Zanca

|Nov 01, 2024
WRAD core perturbation impairs DNA replication fidelity promoting immunoediting in pancreatic cancer.

Francesca Citron, I-Lin Ho, Chiara Balestrieri

|Apr 17, 2023
Ether phospholipids are required for mitochondrial reactive oxygen species homeostasis.

Ziheng Chen, I-Lin Ho, Melinda Soeung

Pageof 1

Frequent Collaborators

5 joint publications

Giulio F Draetta

4 joint publications

Er-Yen Yen

4 joint publications

Linghua Wang

4 joint publications

Giannicola Genovese